Vaccines

29 Jul 2009 MVI and Crucell Announce Collaboration new Malaria Vaccine Approach
29 Jul 2009 Inovio Biomedical Universal Influenza Vaccines Demonstrate 100% Protection Against Current Pandemic A/H1N1 Influenza Viruses in Animal Studies
27 Jul 2009 Sanofi Pasteur strengthens vaccines position in India through the control of Shantha Biotechnics via Mérieux Alliance
27 Jul 2009 Inovio Biomedical Universal Dengue DNA Vaccine Demonstrates Strong Immune Responses Against All Four Serotypes
24 Jul 2009 Immunomedics Partners With Alexis Biotech to Develop Targeted Vaccines in Cancer and AIDS
22 Jul 2009 Sinovac Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza A (H1N1)
22 Jul 2009 Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies
20 Jul 2009 OPKO Acquires Novel Vaccine Technology from Academia Sinica
20 Jul 2009 Generex Publishes Results From Pre-Clinical Studies On Immunotherapeutic Vaccine for HPV-Induced Cervical Cancer
17 Jul 2009 AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine
16 Jul 2009 Medicago's Avian flu pandemic vaccine achieves 100% protection in a lethal challenge study in ferrets
14 Jul 2009 Wyeth's Prevenar 13* Receives First Approval
13 Jul 2009 Inovio Biomedical H1N1 Influenza DNA Vaccines Demonstrate 100% Responses Against Swine Flu in Vaccinated Pigs
08 Jul 2009 Vical TransVax(tm) CMV Vaccine Achieves Promising Interim Clinical Results in Phase 2 Trial
07 Jul 2009 ImmunoVaccine Technologies to Develop Pseudomonas Vaccine from Yokohama City University
07 Jul 2009 Landmark study for GSK’s cervical cancer vaccine published in The Lancet
06 Jul 2009 Oxford Biomedica Announces Outcome of FDA Review And Updates On Trovax® Phase III Trist Study In Renal Cancer
30 Jun 2009 Vical H1 Influenza Vaccine Delivers Robust Preclinical Results With 100% Response
30 Jun 2009 Medicago's vaccine candidate against novel influenza A (H1N1) virus immunogenic in mice
30 Jun 2009 Novartis receives Complete Response letter from the US Food and Drug Administration for its investigational vaccine Menveo
29 Jun 2009 Juvaris BioTherapeutics Announces Strategic Collaboration with Antigen Discovery, Inc.
25 Jun 2009 Apthera Receives Special Protocol Assessment (SPA) From FDA for Pivotal Phase III Trial of NeuVax in Early-Stage Breast Cancer
24 Jun 2009 Preclinical Proof-of-Concept Studies Published for Novavax Seasonal Influenza Virus-Like-Particle Vaccine
22 Jun 2009 Merck Initiates Phase III Study of Stimuvax in Breast Cancer
22 Jun 2009 Néovacs to Expand Clinical Testing of Its TNF-alpha Kinoid Lead Product Candidate Following Positive Preliminary Findings from a Phase I/II Study

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top